Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

65.26 USD -0.68 (-1.03%)
Official Closing Price Updated: 4:00 PM EDT, Jun 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,309,394
Open 66.15
Bid (Size) 65.24 (1)
Ask (Size) 65.40 (6)
Prev. Close 65.94
Today's Range 65.24 - 66.22
52wk Range 55.92 - 67.96
Shares Outstanding 2,232,843,755
Dividend Yield 3.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Eisai, Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate
From ACN Newswire
Bristol Myers Squibb Receives European Commission Approval for Onureg® (azacitidine tablets) as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia
BMS Receives European Commission Approval for Onureg® as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia 
From Business Wire News Releases

Performance

YTD
+6.32%
+6.32%
1 Month
-3.02%
-3.02%
3 Month
+4.22%
+4.22%
6 Month
+6.23%
+6.23%
1 Year
+13.38%
+13.38%

More News

Read More
Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai’s MORAb-202 Antibody Drug Conjugate
From Business Wire News Releases
Bristol Myers Squibb Announces Dividend
From Business Wire News Releases
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
Tags BZI/AUOA ATOS CVS
From Benzinga
Bristol Myers Onureg Scores European Approval As Maintenance Therapy For Acute Myeloid Leukemia
Tags Biotech FDA Market News
From Benzinga
ITOT, JNJ, PFE, BMY: Large Outflows Detected at ETF
Tags ETFs
From ETF Channel
Which Is A Better Investment? Amgen Vs Bristol-Myers Squibb… The Winner May Surprise You
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
Exelixis Announces Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb to Evaluate XL092 in Combination with Immuno-oncology Therapies in Advanced Solid Tumors
From Business Wire News Releases
The 2 Best Pharma Stocks to Buy on Dips
Tags Market News Healthcare Pharma/Biotech
From Blogs - TalkMarkets
Healthcare Portfolio Playbook: Time To Rebalance With MedTech
Tags Market News ETFs Stocks / Equities
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]